SKIN Beauty Health Co

  1. Stocks
  2. Consumer Defensive
  3. NASDAQ: SKIN

Price (delayed)

$0.622

Market cap

$80.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$243.38M

?
Relative Growth: Rel. Growth: 37
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: 64
Relative Profitability: Rel. Profitability: 53

BeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Its flagship brand, HydraFacial, is a non-invasive and approachable beauty health platform and ecosystem with a ...

Highlights
The net income has surged by 84% year-on-year and by 36% since the previous quarter
Beauty Health's EPS has soared by 84% YoY and by 38% from the previous quarter
SKIN's quick ratio has plunged by 77% YoY but it is up by 5% from the previous quarter
The company's equity rose by 20% YoY but it fell by 10% QoQ
The revenue has decreased by 8% YoY
Sector: Consumer Defensive
Industry: Household & Personal Products
Website: http://www.beautyhealth.com/
Peers: ODD

Key stats

What are the main financial stats of SKIN

SKIN stock price

How has the Beauty Health stock price performed over time
Intraday
-1.88%
1 week
-20.82%
1 month
-30.87%
1 year
-62.75%
YTD
-55.25%
QTD
-30.11%

Financial performance

How have Beauty Health's revenue and profit performed over time
Revenue
$296.12M
Gross profit
$192.22M
Operating income
-$10.58M
Net income
-$6.05M
Gross margin
64.9%
Net margin
-2%
The net income has surged by 84% year-on-year and by 36% since the previous quarter
The operating income has soared by 83% year-on-year and by 49% since the previous quarter
SKIN's net margin has soared by 83% year-on-year and by 38% since the previous quarter
The operating margin has soared by 82% YoY and by 48% from the previous quarter

Price vs fundamentals

How does SKIN's price correlate with its fundamentals

Growth

What is Beauty Health's growth rate over time

Valuation

What is Beauty Health stock price valuation
P/E
N/A
P/B
1.44
P/S
0.27
EV/EBIT
12.4
EV/EBITDA
5.51
EV/Sales
0.82
Beauty Health's EPS has soared by 84% YoY and by 38% from the previous quarter
The P/B is 88% below the 5-year quarterly average of 12.5 and 51% below the last 4 quarters average of 3.0
The company's equity rose by 20% YoY but it fell by 10% QoQ
The P/S is 93% less than the 5-year quarterly average of 3.7 and 55% less than the last 4 quarters average of 0.6
The revenue has decreased by 8% YoY

Efficiency

How efficient is Beauty Health business performance
Beauty Health's ROS has soared by 178% YoY and by 47% from the previous quarter
The company's return on equity has surged by 86% YoY and by 38% QoQ
The ROA has soared by 79% YoY and by 29% from the previous quarter
The ROIC has soared by 73% from the previous quarter

Dividends

What is SKIN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SKIN.

Financial health

How did Beauty Health financials performed over time
Beauty Health's total assets is 13% higher than its total liabilities
SKIN's quick ratio has plunged by 77% YoY but it is up by 5% from the previous quarter
The company's current ratio has shrunk by 76% YoY but it rose by 8% QoQ
SKIN's debt to equity is down by 46% year-on-year but it is up by 7% since the previous quarter
SKIN's debt is down by 35% year-on-year and by 3.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.